Orkambi (lumacaftor/ivacaftor)
pCPA File Number:
20755
Negotiation Status:
Negotiations were not pursued
Indication(s):
Cystic Fibrosis, F508del CFTR mutation
Sponsor/Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
CDA-AMC Project Number:
SR0471-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: